Business Food and Beverages Health Industry News Science

Crohn’s Disease Market Insights, Epidemiology, & Market Forecast 2028

Press Release

DelveInsight’s “Crohn’s Disease – Market Insights, Epidemiology and Market Forecast 2028” report provides the detailed overview of the disease and in depth understanding of historical and forecasted epidemiology. It highlights the existing treatment patterns, potential upcoming drugs and also identifies best of the market opportunities by providing the current and forecasted market revenue, sales trends, and drug uptake during the study period from 2016-2028.
Markets Covered

• United States
• EU5 (Germany, France, Italy, Spain and the United Kingdom)
• Japan
Study Period: 2016-2028
Crohn’s Disease Understanding and Treatment Algorithm
The report provides the in depth analysis of the disease overview by providing details such as disease definition, classification, symptoms, etiology, pathophysiology and diagnostic trends. The comprehensive details about treatment algorithms and treatment guidelines for Crohn’s Disease in the US, Europe, and Japan are also provided in the report.
Crohn’s Disease Epidemiology
This section provide the insights about historical and current patient pool and forecasted trend for 7 major markets. It takes in to account the analysis of numerous studies, survey reports as well as KOL’s views which helps to recognize the factors behind the current and forecasted trends, diagnosed and treatable patient pool along with assumptions undertaken.
Crohn’s Disease Product Profiles & Analysis
This part of the Crohn’s Disease report encloses the detailed analysis of marketed drugs and Phase III and late Phase II pipeline drugs. It provides the key cross competition which evaluates the drugs on several parameters including, safety & efficacy results, mechanism of action, route, launch dates and designations. This section also covers the market intelligence and tracking of latest happenings, agreements and collaborations, approvals, patent details and other major breakthroughs.
Crohn’s Disease Market Outlook
The Crohn’s Disease market outlook of the report helps to build the detailed comprehension of the historic, current and forecasted trend of the market by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand of better technology. This segment analyses the market trend of each marketed drug and late-stage pipeline drugs. This is done by evaluating their impact based on annual cost of therapy, inclusion and exclusion criteria’s, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders . The calculated market data is presented with relevant tables and graphs to give a clear view of the market at first sight.
Crohn’s Disease Market Share by Therapies
This section focusses on the rate of uptake of the potential drugs recently launched or will be launched in the market during the study period from 2016-2028. The analysis covers market uptake by drugs; patient uptake by therapies and sales of each drug. This information also helps in understanding the drugs with the most rapid uptake and the reasons behind the maximal use of new drugs. It provides the comparison of the drugs on the basis of market share and size. This analysis helps in investigating factors important in market uptake and in making financial as well as regulatory decisions.
Crohn’s Disease Report Insights

• Patient Population in Crohn’s Disease
• Therapeutic Approaches in Crohn’s Disease
• Crohn’s Disease Pipeline Analysis
• Crohn’s Disease Market Size and Trends
• Crohn’s Disease Market Opportunities
• Impact of upcoming Therapies in Crohn’s Disease Crohn’s Disease

Report Key Strengths
• 10 Year Forecast
• 7MM Coverage
• Epidemiology
Segmentation
• Drugs Uptake
• Highly Analyzed Market
• Key Cross Competition Crohn’s Disease

Report Assessment
• Current Treatment Practices in Crohn’s Disease
• Unmet Needs in Crohn’s Disease
• Detailed Crohn’s Disease Pipeline Product Profiles
• Market Attractiveness
• Market Drivers and Barriers

Key Benefits
• This DelveInsight report will help to develop Business Strategies by understanding the trends shaping and driving the Crohn’s Disease market
• Organize sales and marketing efforts by identifying the best opportunities for Crohn’s Disease market
• To understand the future market competition in the Crohn’s Disease market.

Request for sample pages

Table of contents

  1. Report Introduction
  2. Crohn’s Disease Market Overview at a Glance

2.1. Market Share Distribution of Crohn’s Disease in 2017

2.2. Market Share Distribution of Crohn’s Disease in 2028

  1. Disease Background and Overview: Crohn’s Disease

3.1. Introduction

3.2. Symptoms

3.3. Etiology

3.4. Risk Factors

3.5. Pathophysiology

3.6. Diagnosis

3.7. Treatment

  1. Epidemiology and Patient Population

4.1. Key Findings

4.2. Total Prevalent/ Incident Patient Population of Crohn’s Disease in 7MM

4.3. Total Prevalent Patient Population of Crohn’s Disease in 7MM – By Countries

  1. Epidemiology of Crohn’s Disease by Countries

5.1. United States

5.1.1. Assumptions and Rationale

5.1.2. Prevalent/Incident Cases of the Crohn’s Disease

5.1.3. Sub-Type Specific cases of the Crohn’s Disease *

5.1.4. Sex- Specific Cases of the Crohn’s Disease *

5.1.5. Diagnosed Cases of the Crohn’s Disease

5.1.6. Treatable Cases of the Crohn’s Disease

5.2. EU5

5.3. Assumptions and Rationale

5.4. Germany

5.4.1. Assumptions and Rationale

5.4.2. Prevalent/Incident Cases of the Crohn’s Disease

5.4.3. Sub-Type Specific cases of the Crohn’s Disease *

5.4.4. Sex- Specific Cases of the Crohn’s Disease *

5.4.5. Diagnosed Cases of the Crohn’s Disease

5.4.6. Treatable Cases of the Crohn’s Disease

5.5. France

5.5.1. Assumptions and Rationale

5.5.2. Prevalent/Incident Cases of the Crohn’s Disease

5.5.3. Sub-Type Specific cases of the Crohn’s Disease *

5.5.4. Sex- Specific Cases of the Crohn’s Disease *

5.5.5. Diagnosed Cases of the Crohn’s Disease

5.5.6. Treatable Cases of the Crohn’s Disease

5.6. Italy

5.6.1. Assumptions and Rationale

5.6.2. Prevalent/Incident Cases of the Crohn’s Disease

5.6.3. Sub-Type Specific cases of the Crohn’s Disease *

5.6.4. Sex- Specific Cases of the Crohn’s Disease *

5.6.5. Diagnosed Cases of the Crohn’s Disease

5.6.6. Treatable Cases of the Crohn’s Disease

5.7. Spain

5.7.1. Assumptions and Rationale

5.7.2. Prevalent/Incident Cases of the Crohn’s Disease

5.7.3. Sub-Type Specific cases of the Crohn’s Disease *

5.7.4. Sex- Specific Cases of the Crohn’s Disease *

5.7.5. Diagnosed Cases of the Crohn’s Disease

5.7.6. Treatable Cases of the Crohn’s Disease

5.8. United Kingdom

5.8.1. Assumptions and Rationale

5.8.2. Prevalent/Incident Cases of the Crohn’s Disease

5.8.3. Sub-Type Specific cases of the Crohn’s Disease *

5.8.4. Sex- Specific Cases of the Crohn’s Disease *

5.8.5. Diagnosed Cases of the Crohn’s Disease

5.8.6. Treatable Cases of the Crohn’s Disease 5.9. Japan

5.9.1. Assumptions and Rationale

5.9.2. Prevalent/Incident Cases of the Crohn’s Disease

5.9.3. Sub-Type Specific cases of the Crohn’s Disease *

5.9.4. Sex- Specific Cases of the Crohn’s Disease *

5.9.5. Diagnosed Cases of the Crohn’s Disease

5.9.6. Treatable Cases of the Crohn’s Disease

  1. Current Treatment & Medical practices

6.1. Treatment Algorithm

6.2. Treatment Guidelines

  1. Unmet Needs of the Crohn’s Disease
  2. Marketed Therapies

8.1. Drug A: Company 1

8.1.1. Drug Description

8.1.2. Mechanism of Action

8.1.3. Regulatory Milestones

8.1.4. Advantages & Disadvantages

8.1.5. Product Profile

8.2. Drug B: Company 2

8.2.1. Drug Description

8.2.2. Mechanism of Action

8.2.3. Regulatory Milestones

8.2.4. Advantages & Disadvantages

8.2.5. Product Profile

  1. Pipeline Therapies – At a glance
  2. Key Cross Competition
  3. Emerging Therapies for Crohn’s Disease

11.1. Drug C: Company 3

11.1.1. Drug Description

11.1.2. Clinical Trials Details

11.1.3. Safety and Efficacy Profile

11.1.4. Advantages & Disadvantages

11.1.5. Pipeline Development Activities

11.1.6. Product Profile

11.2. Drug D: Company 4

11.2.1. Drug Description

11.2.2. Clinical Trials Details

11.2.3. Safety and Efficacy Profile

11.2.4. Advantages & Disadvantages

11.2.5. Pipeline Development Activities

11.2.6. Product Profile

  1. Crohn’s Disease : 7MM Market Analysis

12.1. 7MM Market Size of Crohn’s Disease

12.2. 7MM Percentage Share of drugs marketed for Crohn’s Disease

12.3. 7MM Market Sales of Crohn’s Disease by Products

  1. Crohn’s Disease : Country-Wise Market Analysis

13.1. United States

13.1.1. Market Size of Crohn’s Disease in United States

13.1.2. Percentage Share of drugs marketed for Crohn’s Disease in United States

13.1.3. Market Sales of Crohn’s Disease by Products in United States

13.1.4. Analysis of Upcoming Therapies and their Impact on the Market

13.2. EU-5

13.2.1. Germany

13.2.1.1. Market Size of Crohn’s Disease in Germany

13.2.1.2. Percentage Share of drugs marketed for Crohn’s Disease in Germany

13.2.1.3. Market Sales of Crohn’s Disease by Products in Germany

13.2.1.4. Analysis of Upcoming Therapies and their Impact on the Market

13.2.2. France

13.2.2.1. Market Size of Crohn’s Disease in France

13.2.2.2. Percentage Share of drugs marketed for Crohn’s Disease in France

13.2.2.3. Market Sales of Crohn’s Disease by Products in France

13.2.2.4. Analysis of Upcoming Therapies and their Impact on the Market

13.2.3. Italy

13.2.3.1. Market Size of Crohn’s Disease in Italy

13.2.3.2. Percentage Share of drugs marketed for Crohn’s Disease in Italy

13.2.3.3. Market Sales of Crohn’s Disease by Products in Italy

13.2.3.4. Analysis of Upcoming Therapies and their Impact on the Market

13.2.4. Spain

13.2.4.1. Market Size of Crohn’s Disease in Spain

13.2.4.2. Percentage Share of drugs marketed for Crohn’s Disease in Spain

13.2.4.3. Market Sales of Crohn’s Disease by Products in Spain

13.2.4.4. Analysis of Upcoming Therapies and their Impact on the Market

13.2.5. United Kingdom

13.2.5.1. Market Size of Crohn’s Disease in United Kingdom

13.2.5.2. Percentage Share of drugs marketed for Crohn’s Disease in United Kingdom

13.2.5.3. Market Sales of Crohn’s Disease by Products in United Kingdom

13.2.5.4. Analysis of Upcoming Therapies and their Impact on the Market

13.3. Japan

13.3.1. Market Size of Crohn’s Disease in Japan

13.3.2. Percentage Share of drugs marketed for Crohn’s Disease in Japan

13.3.3. Market Sales of Crohn’s Disease by Products in Japan

13.3.4. Analysis of Upcoming Therapies and their Impact on the Market

  1. Market Drivers
  2. Market Barriers
  3. Appendix
  4. Report Methodology

17.1. Sources

  1. DelveInsight Capabilities
  2. Disclaimer
  3. About DelveInsight